Picture1.jpg
D. Boral Capital Served as Co-manager to U.S. Energy Corp. (Nasdaq: USEG) in connection with its up to $12.1 Million Public Offering
27 janv. 2025 13h29 HE | D. Boral Capital
HOUSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ: USEG, “U.S. Energy” or the “Company”) announced today the closing of its previously announced underwritten public offering of...
Picture1.jpg
D. Boral Capital Acted as Joint Bookrunner to Decent Holding Inc. (Nasdaq: DXST) in connection with its $5.0 Million Initial Public Offering
24 janv. 2025 11h46 HE | D. Boral Capital
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- On Jan. 23, 2025, Decent Holding Inc. (Nasdaq: DXST) (the “Company”), an established wastewater treatment services provider in China, announced the...
Picture1.jpg
D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor
21 janv. 2025 08h30 HE | D. Boral Capital
NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, today announced it has secured significant strategic...
Picture1.jpg
D. Boral Capital Served as Placement Agent to Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing
14 janv. 2025 08h00 HE | D. Boral Capital
ONTARIO, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services to...
Picture1.jpg
D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering
07 janv. 2025 11h18 HE | D. Boral Capital
BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the “Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the...
Picture1.jpg
D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering
06 janv. 2025 08h00 HE | D. Boral Capital
WUXI, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and...
Picture1.jpg
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing
30 déc. 2024 14h12 HE | D. Boral Capital
HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
Picture1.jpg
D. Boral Capital Acted as Exclusive Placement Agent to Webuy Global Ltd (Nasdaq: WBUY) in connection with its $3.7 Million Registered Direct Offering
19 déc. 2024 08h00 HE | D. Boral Capital
NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd (Nasdaq: WBUY) (the “Company”), a Southeast Asian community-oriented e-commerce retailor with a focus on grocery and travel, on December...
Picture1.jpg
D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
12 déc. 2024 08h00 HE | D. Boral Capital
CULVER CITY, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public...
Picture1.jpg
D. Boral Capital Acted as Exclusive Placement Agent to Baijiayun Group Ltd (Nasdaq: RTC) in connection with its up to $15 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement
10 déc. 2024 11h17 HE | D. Boral Capital
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, on December 6, 2024, announced that it has...